Tegaderm Vs. Transpore for Eye Protection During Anesthesia

A Randomized Controlled Trial of Tegaderm Vs. Transpore for Eye Protection During Anesthesia

NCT04918290•Tufts Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Eyelid Erythema

Interventions

Tegaderm Eye Tape

Transpore Eye Tape

Locations

United States

Locations (1)

Tufts Medical Center

Boston, Massachusetts, United States

Key Dates

Start Date

June 11, 2021

Primary Completion Date

April 17, 2024

Completion Date

May 15, 2024

Last Updated

October 28, 2024

Sponsors

Lead Sponsor

Tufts Medical Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 28, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions